MediFind
Condition

Lung Cancer

Latest Research

Latest Advance
Study
  • Condition: Peripheral Early-Stage Non-Small Cell Lung Cancer
  • Journal: Advances in radiation oncology
  • Treatment Used: Single-Fraction Stereotactic Body Radiation Therapy (SBRT)
  • Published —
This article discusses the use of SBRT to treat patients with non-small cell lung cancer during the COVID-19 pandemic.
Latest Advance
Study
  • Condition: Patients with PD-L1-High (?50%) Non-Small Cell Lung Cancer (NSCLC) and Poor Performance
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: First-Line Pembrolizumab
  • Number of Patients: 234
  • Published —
This study evaluated outcomes for first-line pembrolizumab in patients with advanced non-small cell lung cancer (NSCLC) with poor performance.
Latest Advance
Study
  • Condition: Non-small Cell Lung Cancer
  • Journal: Scientific reports
  • Treatment Used: Pembrolizumab Versus Nivolumab
  • Number of Patients: 255
  • Published —
In this study, researchers compared the effectiveness of pembrolizumab versus nivolumab for the treatment of recurrent or advanced non-small cell lung cancer.
Latest Advance
Study
  • Condition: Non-Small Cell Lung Cancer (NSCLC)
  • Journal: Journal of hematology & oncology
  • Treatment Used: Stereotactic Body Radiation Therapy (SBRT) Combined with PD-1/PD-L1 Inhibitors
  • Published —
This article discusses recent advances for stereotactic body radiation therapy (SBRT) combined with programmed cell death 1 (PD-1), programmed cell death ligand-1 (PD-L1) inhibitors in the treatment of non-small cell lung cancer (NSCLC).
Latest Advance
Study
  • Condition: Leptomeningeal Metastases (LM) in Non-small Cell Lung Cancer (NSCLC)
  • Journal: Current treatment options in oncology
  • Treatment Used: Chemotherapy, Radiation, and Drug Therapy
  • Published —
This article discusses recent advances in diagnosis, monitoring, and treatment of leptomeningeal metastasis (LM) in non-small cell lung cancer (NSCLC).
Latest Advance
Study
  • Condition: COVID-19
  • Journal: Seminars in oncology
  • Treatment Used: RRx-001
  • Published —
This article summarizes the potential ability for RRx-001 to attenuate the respiratory effects of COVID-19.
Latest Advance
Study
  • Condition: Non-Small Cell Lung Cancer (NSCLC)
  • Journal: Current treatment options in oncology
  • Treatment Used: Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment
  • Published —
This article discusses immunotherapy alone or in combination with chemotherapy as first-line treatment for patients with non-small cell lung cancer (NSCLC).
Latest Advance
Study
  • Condition: Gynecologic Cancers
  • Journal: International journal of molecular sciences
  • Treatment Used: PD-1/PD-L1 Inhibitor
  • Published —
This review of the literature described the safety and effectiveness anti-PD-1/PD-L1 antibodies in gynecological cancers.
Latest Advance
Study
  • Condition: Non-small cell Lung Cancer
  • Journal: Journal of biomedical science
  • Treatment Used: Precision Radiotherapy
  • Number of Patients: N/A
  • Published —
The study researched using precision radiotherapy to treat non-small cell lung cancer.
Latest Advance
Study
  • Condition: COVID-19 Pneumonia in Wuhan, China
  • Journal: Journal of X-ray science and technology
  • Treatment Used: Steroids and Computed tomography (CT)
  • Number of Patients: 3
  • Published —
This article analyzed and reported the cases of patients with COVID-19 pneumonia who received titrated steroids treatment based on the assessment of computed tomography (CT) images augmented and analyzed with the artificial intelligence (AI) tool and output.
Latest Advance
Study
  • Condition: EGFR-mutant Non-small Cell Lung Cancer with Brain Metastasis
  • Journal: Aging
  • Treatment Used: Various
  • Number of Patients: 1173
  • Published —
In this study, researchers sought to determine the best treatment for EGFR-mutant non-small cell lung cancer with brain metastasis.
Latest Advance
Study
  • Condition: Lung Adenocarcinoma
  • Journal: BMC cancer
  • Treatment Used: Radiation and Tyrosine Kinase Inhibitors
  • Number of Patients: 132
  • Published —
The study researched the management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations.